114 related articles for article (PubMed ID: 29338557)
1. Biosynthesis, characterization and leishmanicidal activity of a biocomposite containing AgNPs-PVP-glucantime.
Gélvez APC; Farias LHS; Pereira VS; da Silva ICM; Costa AC; Dias CGBT; Costa RMR; da Silva SHM; Rodrigues APD
Nanomedicine (Lond); 2018 Feb; 13(4):373-390. PubMed ID: 29338557
[TBL] [Abstract][Full Text] [Related]
2. AgNP-PVP-meglumine antimoniate nanocomposite reduces Leishmania amazonensis infection in macrophages.
Gélvez APC; Diniz Junior JAP; Brígida RTSS; Rodrigues APD
BMC Microbiol; 2021 Jul; 21(1):211. PubMed ID: 34253188
[TBL] [Abstract][Full Text] [Related]
3. Decanethiol functionalized silver nanoparticles are new powerful leishmanicidals in vitro.
Isaac-Márquez AP; Talamás-Rohana P; Galindo-Sevilla N; Gaitan-Puch SE; Díaz-Díaz NA; Hernández-Ballina GA; Lezama-Dávila CM
World J Microbiol Biotechnol; 2018 Feb; 34(3):38. PubMed ID: 29460068
[TBL] [Abstract][Full Text] [Related]
4. The combination therapy of meglumine antimoniate and oxiranes (epoxy-α-lapachone and epoxymethyl-lawsone) enhance the leishmanicidal effect in mice infected by Leishmania (Leishmania) amazonensis.
Gonçalves-Oliveira LF; Souza-Silva F; de Castro Côrtes LM; Veloso LB; Santini Pereira BA; Cysne-Finkelstein L; Lechuga GC; Bourguignon SC; Almeida-Souza F; da Silva Calabrese K; Ferreira VF; Alves CR
Int J Parasitol Drugs Drug Resist; 2019 Aug; 10():101-108. PubMed ID: 31430693
[TBL] [Abstract][Full Text] [Related]
5. Clinical and laboratory evaluation of cured and non-cured patients with cutaneous leishmaniasis treated by Glucantime.
Ezatkhah F; Sharifi I; Babaei Z; Baneshi MR; Zolala F; Kermanizadeh A; Keyhani A; Sharifi M; Dezaki ES; Aflatoonian MR; Aflatoonian B; Khatami M; Bamorovat M
J Vector Borne Dis; 2019; 56(4):351-359. PubMed ID: 33269736
[TBL] [Abstract][Full Text] [Related]
6. Chitosan-titanium dioxide-glucantime nanoassemblies effects on promastigote and amastigote of Leishmania major.
Varshosaz J; Arbabi B; Pestehchian N; Saberi S; Delavari M
Int J Biol Macromol; 2018 Feb; 107(Pt A):212-221. PubMed ID: 28867228
[TBL] [Abstract][Full Text] [Related]
7. A Novel Niosomal Combination of Selenium Coupled with Glucantime against Leishmania tropica.
Mostafavi M; Khazaeli P; Sharifi I; Farajzadeh S; Sharifi H; Keyhani A; Parizi MH; Kakooei S
Korean J Parasitol; 2019 Feb; 57(1):1-8. PubMed ID: 30840792
[TBL] [Abstract][Full Text] [Related]
8. A nanotechnology based new approach for chemotherapy of Cutaneous Leishmaniasis: TIO2@AG nanoparticles - Nigella sativa oil combinations.
Abamor ES; Allahverdiyev AM
Exp Parasitol; 2016 Jul; 166():150-63. PubMed ID: 27109311
[TBL] [Abstract][Full Text] [Related]
9. Semicarbazone derivatives as promising therapeutic alternatives in leishmaniasis.
Cavalcanti de Queiroz A; Alves MA; Barreiro EJ; Lima LM; Alexandre-Moreira MS
Exp Parasitol; 2019 Jun; 201():57-66. PubMed ID: 31004571
[TBL] [Abstract][Full Text] [Related]
10. The activity of encapsulated meglumine antimoniate in stearylamine-bearing liposomes against cutaneous leishmaniasis in BALB/c mice.
Moosavian SA; Fallah M; Jaafari MR
Exp Parasitol; 2019 May; 200():30-35. PubMed ID: 30898544
[TBL] [Abstract][Full Text] [Related]
11. Sugar-based colloidal nanocarriers for topical meglumine antimoniate application to cutaneous leishmaniasis treatment: Ex vivo cutaneous retention and in vivo evaluation.
Aragão Horoiwa T; Cortez M; Sauter IP; Migotto A; Bandeira CL; Cerize NNP; de Oliveira AM
Eur J Pharm Sci; 2020 Apr; 147():105295. PubMed ID: 32145429
[TBL] [Abstract][Full Text] [Related]
12. Biocompatible silver nanoparticles reduced from Anethum graveolens leaf extract augments the antileishmanial efficacy of miltefosine.
Kalangi SK; Dayakar A; Gangappa D; Sathyavathi R; Maurya RS; Narayana Rao D
Exp Parasitol; 2016 Nov; 170():184-192. PubMed ID: 27622989
[TBL] [Abstract][Full Text] [Related]
13. Bovine serum albumin nanoparticles containing amphotericin B were effective in treating murine cutaneous leishmaniasis and reduced the drug toxicity.
Casa DM; Scariot DB; Khalil NM; Nakamura CV; Mainardes RM
Exp Parasitol; 2018 Sep; 192():12-18. PubMed ID: 30026113
[TBL] [Abstract][Full Text] [Related]
14. Bioreactor validation and biocompatibility of Ag/poly(N-vinyl-2-pyrrolidone) hydrogel nanocomposites.
Jovanović Z; Radosavljević A; Kačarević-Popović Z; Stojkovska J; Perić-Grujić A; Ristić M; Matić IZ; Juranić ZD; Obradovic B; Mišković-Stanković V
Colloids Surf B Biointerfaces; 2013 May; 105():230-5. PubMed ID: 23376750
[TBL] [Abstract][Full Text] [Related]
15. A single-group trial of end-stage patients with anthroponotic cutaneous leishmaniasis: Levamisole in combination with Glucantime in field and laboratory models.
Bamorovat M; Sharifi I; Fekri A; Keyhani A; Aflatoonian MR; Heshmatkhah A; Oliaee RT; Khosravi A; Naderi A; Parizi MH; Mostafavi M; Varma RS
Microb Pathog; 2019 Mar; 128():162-170. PubMed ID: 30583021
[TBL] [Abstract][Full Text] [Related]
16. In vitro analysis regarding the safety of components used in a film-based therapeutic system loaded with meglumine antimoniate and its activity toward Leishmania major experimental infections: a preliminary study.
Gutiérrez J; Vallejo B; Barbosa H; Pinzón J; Delgado G
Immunopharmacol Immunotoxicol; 2013 Jun; 35(3):321-8. PubMed ID: 23473403
[TBL] [Abstract][Full Text] [Related]
17. Lipid nanoparticles for amphotericin delivery in the treatment of American tegumentary leishmaniasis.
de Souza RM; Maranhão RC; Tavares ER; Filippin-Monteiro FB; Nicodemo AC; Morikawa AT; Kanashiro EHY; Amato VS
Drug Deliv Transl Res; 2020 Apr; 10(2):403-412. PubMed ID: 31701487
[TBL] [Abstract][Full Text] [Related]
18. Potential utility of hyperbaric oxygen therapy and propolis in enhancing the leishmanicidal activity of glucantime.
Ayres DC; Fedele TA; Marcucci MC; Giorgio S
Rev Inst Med Trop Sao Paulo; 2011; 53(6):329-34. PubMed ID: 22183457
[TBL] [Abstract][Full Text] [Related]
19. Isatis tinctoria mediated synthesis of amphotericin B-bound silver nanoparticles with enhanced photoinduced antileishmanial activity: A novel green approach.
Ahmad A; Wei Y; Syed F; Khan S; Khan GM; Tahir K; Khan AU; Raza M; Khan FU; Yuan Q
J Photochem Photobiol B; 2016 Aug; 161():17-24. PubMed ID: 27203567
[TBL] [Abstract][Full Text] [Related]
20. Quercetin-mediated synthesis of graphene oxide-silver nanoparticle nanocomposites: a suitable alternative nanotherapy for neuroblastoma.
Yuan YG; Wang YH; Xing HH; Gurunathan S
Int J Nanomedicine; 2017; 12():5819-5839. PubMed ID: 28860751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
